Abstract

Inflammatory cytokines are key signaling molecules that can promote an immune response, thus their RNA turnover must be tightly controlled during infection. Most studies investigate the RNA decay pathways in the cytosol or nucleoplasm but never focused on the nucleolus. Although this organelle has well-studied roles in ribosome biogenesis and cellular stress sensing, the mechanism of RNA decay within the nucleolus is not completely understood. Here, we report that the nucleolus is an essential site of inflammatory pre-mRNA instability during infection. RNA-sequencing analysis reveals that not only do inflammatory genes have higher intronic read densities compared with non-inflammatory genes, but their pre-mRNAs are highly enriched in nucleoli during infection. Notably, nucleolin (NCL) acts as a guide factor for recruiting cytosine or uracil (C/U)-rich sequence-containing inflammatory pre-mRNAs and the Rrp6-exosome complex to the nucleolus through a physical interaction, thereby enabling targeted RNA delivery to Rrp6-exosomes and subsequent degradation. Consequently, Ncl depletion causes aberrant hyperinflammation, resulting in a severe lethality in response to LPS. Importantly, the dynamics of NCL post-translational modifications determine its functional activity in phases of LPS. This process represents a nucleolus-dependent pathway for maintaining inflammatory gene expression integrity and immunological homeostasis during infection.

The nucleolus is the traditional site for ribosomal RNA biogenesis. Here, the authors find that the nucleolus is a site of inflammatory pre-mRNA turnover and elucidated how immune homeostasis can be maintained by controlling inflammatory gene expression.

Details

Title
The nucleolus is the site for inflammatory RNA decay during infection
Author
Lee, Taeyun A. 1 ; Han, Heonjong 2 ; Polash, Ahsan 3   VIAFID ORCID Logo  ; Cho, Seok Keun 1 ; Lee, Ji Won 4 ; Ra, Eun A. 1 ; Lee, Eunhye 1 ; Park, Areum 1 ; Kang, Sujin 1 ; Choi, Junhee L. 1 ; Kim, Ji Hyun 5 ; Lee, Ji Eun 6 ; Min, Kyung-Won 7 ; Yang, Seong Wook 1 ; Hafner, Markus 3   VIAFID ORCID Logo  ; Lee, Insuk 8 ; Yoon, Je-Hyun 9   VIAFID ORCID Logo  ; Lee, Sungwook 10   VIAFID ORCID Logo  ; Park, Boyoun 1   VIAFID ORCID Logo 

 Yonsei University, Department of Systems Biology, College of Life Science and Biotechnology, Seoul, South Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454) 
 Yonsei University, Department of Systems Biology, College of Life Science and Biotechnology, Seoul, South Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454); Yonsei University, Department of Biotechnology, College of Life Science and Biotechnology, Seoul, South Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454); National Cancer Center, Division of Tumor Immunology, Research Institute, Goyang, South Korea (GRID:grid.410914.9) (ISNI:0000 0004 0628 9810) 
 National Institutes of Health, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute for Arthritis and Musculoskeletal and Skin Disease, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165) 
 Gangneung-Wonju National University, Department of Biology, College of Natural Sciences, Gangneung, South Korea (GRID:grid.411733.3) (ISNI:0000 0004 0532 811X) 
 Sungkyunkwan University, Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Seoul, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X) 
 Sungkyunkwan University, Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Seoul, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Samsung Medical Center, Samsung Genome Institute (SGI), Seoul, South Korea (GRID:grid.414964.a) (ISNI:0000 0001 0640 5613) 
 Gangneung-Wonju National University, Department of Biology, College of Natural Sciences, Gangneung, South Korea (GRID:grid.411733.3) (ISNI:0000 0004 0532 811X); Medical University of South Carolina, Department of Biochemistry and Molecular Biology, Charleston, USA (GRID:grid.259828.c) (ISNI:0000 0001 2189 3475) 
 Yonsei University, Department of Biotechnology, College of Life Science and Biotechnology, Seoul, South Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454) 
 Medical University of South Carolina, Department of Biochemistry and Molecular Biology, Charleston, USA (GRID:grid.259828.c) (ISNI:0000 0001 2189 3475) 
10  National Cancer Center, Division of Tumor Immunology, Research Institute, Goyang, South Korea (GRID:grid.410914.9) (ISNI:0000 0004 0628 9810) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2709395930
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.